Press Releases

Leisa Dennehy Named Practice Leader for Constella Health Strategies

"Leisa's experience in the pharmaceutical world gives her great insight into the issues that matter most," says Donato Tramuto, President and CEO of Constella Health Strategies. "Her tremendous knowledge of the commercialization of products, portfolios and clients, coupled with her broad profit and loss responsibilities, create a combined background that is both familiar to and in great demand by our clients."

Dennehy previously served as vice president of marketing and corporate officer for Intrabiotics Pharmaceuticals, Inc., and as president and founder of Biopharma Strategies Group, Inc. She also has 17 years of commercial experience with global organizations such as Procter & Gamble and GlaxoSmithKline, formerly Glaxo Wellcome. Her executive-level success in organizational and product strategy, product life cycle management, and product and business development has been instrumental in her approach to strategic and marketing planning.

"The pharmaceutical industry is facing an impending crisis of how to commercialize products. Many excellent drugs are going off patent within the next five years, and pipelines are dwindling," said Dennehy. "Constella Health Strategies is at the forefront of the consulting industry in strategically integrating clinical, economic and market information to assess products and therapy areas and to develop commercial strategies that drive brand success. I'm pleased to work with such incredible talent within Constella, where we'll deliver a new paradigm in pharmaceutical commercialization to our clients."

Dennehy received her M.B.A from Duke University and a B.S. in medical technology and a B.A. in chemistry from Miami University, Oxford, Ohio.

About Constella Health Strategies
Constella Health Strategies is a premier evidence-based, health-care consulting business that helps pharmaceutical, biotechnology and medical device companies around the world accelerate medical therapies to market. Employing one of the largest and most experienced clinical, analytic, technical, and business development teams in the nation, Constella Health Strategies evaluates the best way to use drugs and to provide health care through expert analysis of proprietary databases, consensus panels and scientific literature. Its multidisciplinary staff also designs, develops and implements disease management and other clinically directed programs to reduce unnecessary costs, improve quality, and enhance patient and provider satisfaction.

About Constella Group, Inc.
Constella Group, Inc., formerly named Analytical Sciences, Inc. (ASI), is a leading provider of professional health services worldwide, now celebrating 20 years of enhancing human health through innovative science, technology and knowledge solutions. Constella's three business units—Health Sciences, Biomedical Informatics and Health Strategies—conduct health research and provide a variety of technical, professional and strategic consulting services to help industry and government clients identify and solve problems affecting human health. The company's 640 employees serve clients from company headquarters in Durham, N.C., and from offices in Atlanta; Austin, Texas; Morgantown, W.Va.; Bethesda, Frederick and Silver Spring, Md; and in Santa Monica, Calif.; Herndon, Va; and Boston.